4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-047125
EVP, Chief Financial Officer sold 10,000 shares at $29.00 ($289,970)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-08-21 | Sale 10b5-1 | −10,000 | $29.00 | $289,970 | 15,682 | D |
| Open-market sales · 10,000 sh · avg $29.00 · $289,970 | |||||||
Loading xslF345X05/doc4.xml…